Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
10 December 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
22 April 2024
Press Releases
Foley Adds IP Partners Ngai Zhang and Drew Schulte, Enhancing Innovative Technology Capabilities
Foley & Lardner LLP announced today that it has bolstered its Innovative Technology Sector and Electronics Practice with the addition of partners Ngai Zhang and Drew Schulte in Washington, D.C. and Miami, respectively.
15 April 2024
Press Releases
Foley Names Andrew Wronski as Manufacturing Sector Chair
Foley & Lardner LLP is pleased to announce that Andrew “Andy” Wronski has been named chair of the firm’s Manufacturing Sector, effective April 15, 2024.
03 April 2024
Press Releases
Foley Continues East Coast Growth with Transactions Partner Joe Bernardi, Strengthening Capabilities in the Technology Sector
Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology Sector and Private Equity and M&A Practices with the addition of partner Joe Bernardi in Boston.